China State Council Pushes For Healthcare Reform Deliverables
This article was originally published in PharmAsia News
Executive Summary
China's State Council recently made arrangements to deepen the healthcare system reform. The cabinet is pressing for the national essential drug list to be issued this year, with 30 percent of urban community healthcare institutions and county-level grassroots clinics implementing the list by the end of the year. In addition, the State Council is pushing for public hospital reform pilots in early 2010. Informed sources revealed that the upcoming list includes about 600 medicines which have been covered by the drug catalogue of medical insurance. The pilots for public hospital will establish a legal entity, set up a board of management comprising external personnel, reform compensation mechanisms and explore separate systems for effective management and operation. (Click here for more - Chinese Language)
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.